Safety of Anti-Vascular Endothelial Growth Factor (anti-VEGF) Intravitreal Injections for the Treatment of Patients with Age-Related Macular Degeneration (AMD)

被引：0
|
作者：
Moura, Cristiano S. [1 ]
Machado, Marina A. A. [1 ]
Behlouli, Hassan [1 ]
Campbell, Robert [2 ]
Bernatsky, Sasha [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Queens Univ, Kingston, ON, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
97
引用
收藏
页码：61 / 62
页数：2
相关论文
共 50 条
  • [1] Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age-Related Macular Degeneration
    Bolling, James P.
    [J]. CURRENT DRUG THERAPY, 2012, 7 (02) : 90 - 95
  • [2] Comparison of Treatment Intervals for Various Anti-Vascular Growth Factor (Anti-Vegf) Injections in Wet Age-Related Macular Degeneration Patients
    Marino, Domenica Ida
    Miller, Chase W.
    McCrossin, Christina
    Miller, David G.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [3] Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration
    Jeganathan, V. Swetha E.
    Verma, Nitin
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2009, 20 (03) : 223 - 225
  • [4] Factors associated with switching intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in the treatment of neovascular age-related macular degeneration (nAMD)
    Mauger, Stephanie
    O'Neill, Charles
    Do, Giang
    Lindenberg, Sophiana
    Karamat, Ayesha Nuri
    Corradetti, Giulia
    Tojjar, Jasaman
    Almidani, Louay
    Nittala, Muneeswar Gupta
    Chauhan, Devinder
    Sadda, SriniVas R.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [5] Systemic safety of intravitreal anti-vascular endothelial growth factor agents in age-related macular degeneration
    Dedania, Vaidehi S.
    Bakri, Sophie J.
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2016, 27 (03) : 224 - 243
  • [6] Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
    Joel Hanhart
    Rony Wiener
    Hashem Totah
    Evgeny Gelman
    Yishay Weill
    Adi Abulafia
    David Zadok
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 1907 - 1914
  • [7] Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
    Hanhart, Joel
    Wiener, Rony
    Totah, Hashem
    Gelman, Evgeny
    Weill, Yishay
    Abulafia, Adi
    Zadok, David
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (06) : 1907 - 1914
  • [8] Endophthalmitis Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Neovascular Age-Related Macular Degeneration
    Moshfeghi, Andrew A.
    [J]. SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 139 - 148
  • [9] Predictors of Response to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration
    Shah, Anjali
    Williams, Steven
    Baumal, Caroline
    Rosner, Bernard
    Duker, Jay S.
    Seddon, Johanna
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [10] Predictors of Response to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration
    Shah, Anjali R.
    Williams, Steven
    Baumal, Caroline R.
    Rosner, Bernard
    Duker, Jay S.
    Seddon, Johanna M.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 163 : 154 - 166
12345